More Than a Decade of Molecular Diagnostic Cytopathology Leading Diagnostic and Therapeutic Decision-Making.

作者: Manuel Salto-Tellez

DOI: 10.5858/ARPA.2017-0258-ED

关键词:

摘要:

参考文章(13)
B. Pang, D. Matthias, C. W. Ong, A. N. Dhewar, S. Gupta, G. L. Lim, M. E. Nga, J. E. Seet, A. Qasim, T. M. Chin, R. Soo, R. Soong, M. Salto-Tellez, The positive impact of cytological specimens for EGFR mutation testing in non-small cell lung cancer: a single South East Asian laboratory's analysis of 670 cases. Cytopathology. ,vol. 23, pp. 229- 236 ,(2012) , 10.1111/J.1365-2303.2012.01000.X
M. Salto-Tellez, Diagnostic Molecular Cytopathology - a further decade of progress. Cytopathology. ,vol. 26, pp. 269- 270 ,(2015) , 10.1111/CYT.12276
Neal I. Lindeman, Philip T. Cagle, Mary Beth Beasley, Dhananjay Arun Chitale, Sanja Dacic, Giuseppe Giaccone, Robert Brian Jenkins, David J. Kwiatkowski, Juan-Sebastian Saldivar, Jeremy Squire, Erik Thunnissen, Marc Ladanyi, Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology Journal of Thoracic Oncology. ,vol. 8, pp. 823- 859 ,(2013) , 10.1097/JTO.0B013E318290868F
M. J. Neat, N. J. Foot, A. Hicks, R. Breen, B. Wilkins, E. McLean, G. Santis, ALK rearrangements in EBUS-derived transbronchial needle aspiration cytology in lung cancer. Cytopathology. ,vol. 24, pp. 356- 364 ,(2013) , 10.1111/CYT.12060
Manuel Salto-Tellez, David Gonzalez de Castro, Next-generation sequencing: a change of paradigm in molecular diagnostic validation The Journal of Pathology. ,vol. 234, pp. 5- 10 ,(2014) , 10.1002/PATH.4365
M. Salto-Tellez, E. S. C. Koay, Molecular diagnostic cytopathology: definitions, scope and clinical utility. Cytopathology. ,vol. 15, pp. 252- 255 ,(2004) , 10.1111/J.1365-2303.2004.00195.X
Manuel Salto-Tellez, A Case for Integrated Morphomolecular Diagnostic Pathologists Clinical Chemistry. ,vol. 53, pp. 1188- 1190 ,(2007) , 10.1373/CLINCHEM.2007.088088
Yuri E. Nikiforov, Sally E. Carty, Simon I. Chiosea, Christopher Coyne, Umamaheswar Duvvuri, Robert L. Ferris, William E. Gooding, Shane O. LeBeau, N. Paul Ohori, Raja R. Seethala, Mitchell E. Tublin, Linwah Yip, Marina N. Nikiforova, Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology Thyroid. ,vol. 25, pp. 1217- 1223 ,(2015) , 10.1089/THY.2015.0305
C Flynn, J James, P Maxwell, S McQuaid, A Ervine, M Catherwood, M B Loughrey, D McGibben, J Somerville, D T McManus, M Gray, B Herron, M Salto-Tellez, Integrating molecular diagnostics into histopathology training: the Belfast model Journal of Clinical Pathology. ,vol. 67, pp. 632- 636 ,(2014) , 10.1136/JCLINPATH-2014-202176
L. Capelli, C. Marfisi, M. Puccetti, L. Saragoni, F. De Paola, A. Zaccaroni, E. Chiadini, L. Gagliardi, G. Ferretti, W. Zoli, P. Ulivi, Role of BRAF molecular analysis in the management of papillary thyroid carcinoma: analysis of cytological and histological samples. Cytopathology. ,vol. 26, pp. 297- 302 ,(2015) , 10.1111/CYT.12199